ST1 owns original key technologies that enable the production of various biomaterials. We do this by combing our own electrospinning technology with 3D bio-printing technology.
With our original technologies, we conduct R&D of various products to expand to the fields of biomaterials, medical devices, tissue regeneration, as well as 3D cell culture products.
3D cell culture
3D cell culture products and expansion of technology
Biomaterials
biomaterials utilizing biocompatible materials
Medical devices
medical devices utilizing nanofibers and collagen
Regenerative medicine
study stem cells for tissue regeneration and drug delivery systems
We can be a best partner of your business
Views: 120